Story thread · 2 reports / 2 sources
Selution SLR Drug-Eluting Balloon Gets FDA Nod for Coronary In-Stent Restenosis
medpagetoday.com · 23h · first report
(MedPage Today) -- The FDA approved the Selution sustained limus release (SLR) drug-eluting balloon (DEB or DCB) to treat coronary in-stent restenosis (ISR), Cordis announced Monday. This makes Selution SLR the only sirolimus-based DEB available...
The coverage
- Cordis wins FDA approval for sirolimus-eluting balloon
medtechdive.com · 10h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.